UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 5 Issue 7
July-2018
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1807666


Registration ID:
185427

Page Number

442-450

Share This Article


Jetir RMS

Title

Enhancing Invitro Drug Release of Pioglitazone using Superdisintegrants-FDT

Abstract

In this paper we are present study was to prepare fast dissolving tablets of a hypoglycemic drug Pioglitazone hydrochloride using solid dispersion. One of the major problems with this drug is its low solubility, which results in poor bioavailability after oral administration. The solubility of poorly soluble drug was enhanced by preparing solid dispersions of the drug by PEG 4000 as carrier. Solid dispersion formulations were prepared using different ratios of drug and carrier i.e. 1:1, 1:2: 1:3 and 1:4; respectively by conventional solvent evaporation method. The optimized solid dispersions were further kneaded with suitable proportions of superdisintegrants such as Crosspovidone, Sodium starch Glycolate, Crosscarmellose sodium and different diluents avicel, mannitol and lactose etc. FT-IR spectroscopy, differential scanning calorimetry and U.V spectroscopy, solubility determination, partition coefficient etc studies were carried out in order to characterize the drug and solid dispersion and it showed no evidence of drug-excipient interaction. The prepared formulations were evaluated for thickness, hardness, friability, weight variation, water absorption ratio, wetting time, in-vitro disintegration time and in-vitro dissolution studies. The maximum drug release was found in formulation PGHT8 (97.842%). It was concluded that fast dissolving tablets of pioglitazone hydrochloride prepared by solid dispersions of drug with PEG 4000 and combination of diluents and cross povidone as superdisintegrant provide complete and better dissolution within in shorter period of time. Hence effective diabetic treatment anywhere, and at anytime particularly for geriatric, pediatric, mentally ill, bedridden and patients who do not have easy access to water can be done.

Key Words

Pioglitazone hydrochloride, PEG 4000, cross povidone, SSG, solid dispersion, fast dissolving tablets.

Cite This Article

"Enhancing Invitro Drug Release of Pioglitazone using Superdisintegrants-FDT ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 7, page no.442-450, July-2018, Available :http://www.jetir.org/papers/JETIR1807666.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Enhancing Invitro Drug Release of Pioglitazone using Superdisintegrants-FDT ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 7, page no. pp442-450, July-2018, Available at : http://www.jetir.org/papers/JETIR1807666.pdf

Publication Details

Published Paper ID: JETIR1807666
Registration ID: 185427
Published In: Volume 5 | Issue 7 | Year July-2018
DOI (Digital Object Identifier):
Page No: 442-450
Country: Ajmer, Rajasthan, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002868

Print This Page

Current Call For Paper

Jetir RMS